Dr. Memarzadeh on Hormonal Therapy for Endometrial Tumors

Sanaz Memarzadeh, MD, PhD
Published: Friday, Mar 13, 2015



Sanaz Memarzadeh, MD, PhD associate professor of obstetrics and gynecology and the director of the Gynecologic Oncology (GO) discovery Lab at UCLA, discusses the benefits of hormonal therapy for endometrial tumors.

Endometrial tumors are hormonally regulated, but hormonal therapy is not widely used to treat this subtype. This is mainly due to a lack of understanding of its effects, said Memarzadeh. 

Memarzadeh’s team determined that supporting stromal cells surrounding an endometrial tumor which  are most commonly ignored, are the cells that exert the progesterone  anti-cancer effects.




Sanaz Memarzadeh, MD, PhD associate professor of obstetrics and gynecology and the director of the Gynecologic Oncology (GO) discovery Lab at UCLA, discusses the benefits of hormonal therapy for endometrial tumors.

Endometrial tumors are hormonally regulated, but hormonal therapy is not widely used to treat this subtype. This is mainly due to a lack of understanding of its effects, said Memarzadeh. 

Memarzadeh’s team determined that supporting stromal cells surrounding an endometrial tumor which  are most commonly ignored, are the cells that exert the progesterone  anti-cancer effects.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x